OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phosphodiesterase regulation of alcohol drinking in rodents
Marian L. Logrip
Alcohol (2015) Vol. 49, Iss. 8, pp. 795-802
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond
George S. Baillie, Gonzalo S. Tejeda, Michy P. Kelly
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 10, pp. 770-796
Open Access | Times Cited: 281

Neuroimmune signaling in alcohol use disorder
Emma K. Erickson, Emily K. Grantham, Anna S. Warden, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 177, pp. 34-60
Open Access | Times Cited: 185

Alcohol and the brain: from genes to circuits
Gábor Egervári, Cody A. Siciliano, Ellanor L. Whiteley, et al.
Trends in Neurosciences (2021) Vol. 44, Iss. 12, pp. 1004-1015
Open Access | Times Cited: 72

Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities
Mark D. Namba, Jonna M. Leyrer‐Jackson, Erin K. Nagy, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 56

Immune treatments for alcohol use disorder: A translational framework
Lindsay R. Meredith, Elizabeth M. Burnette, Erica N. Grodin, et al.
Brain Behavior and Immunity (2021) Vol. 97, pp. 349-364
Open Access | Times Cited: 41

Novel medications for problematic alcohol use
Markus Heilig, Katie Witkiewitz, Lara A. Ray, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 11
Open Access | Times Cited: 6

Proteomic Analysis of Chronic Binge Alcohol-Induced Hippocampal and Anterior Cingulate Cortex Neuroadaptations in Simian Immunodeficiency Virus (SIV)-Infected Female Rhesus Macaques
Taylor Fitzpatrick‐Schmidt, Amirsalar Mansouri, Jiří Adamec, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access

Its complicated: The relationship between alcohol and microglia in the search for novel pharmacotherapeutic targets for alcohol use disorders
Jennifer K. Melbourne, Keith Thompson, Hui Peng, et al.
Progress in molecular biology and translational science (2019), pp. 179-221
Closed Access | Times Cited: 40

Genome-wide analysis of the nucleus accumbens identifies DNA methylation signals differentiating low/binge from heavy alcohol drinking
Rita Cervera‐Juanes, Larry Wilhelm, Byung Park, et al.
Alcohol (2016) Vol. 60, pp. 103-113
Open Access | Times Cited: 37

PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder
Ji Soo Lee, Emma M. O’Connell, Pál Pacher, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1758-1758
Open Access | Times Cited: 26

Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial
Erica N. Grodin, Steven J. Nieto, Lindsay R. Meredith, et al.
Addiction Biology (2022) Vol. 27, Iss. 4
Open Access | Times Cited: 16

Discovery of 4-Ethoxy-6-chloro-5-azaindazoles as Novel PDE4 Inhibitors for the Treatment of Alcohol Use Disorder and Alcoholic Liver Diseases
Lei Zheng, Zulihuma Aimaiti, Lu Long, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 728-753
Closed Access | Times Cited: 10

Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities
Christopher M. Olsen, Qing-song Liu
Frontiers in Biology (2016) Vol. 11, Iss. 5, pp. 376-386
Open Access | Times Cited: 29

The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice
Xin Liu, Pi‐da Hao, Mingfeng Yang, et al.
Psychopharmacology (2017) Vol. 234, Iss. 16, pp. 2409-2419
Closed Access | Times Cited: 29

Genetic loci for alcohol-related life events and substance-induced affective symptoms: indexing the “dark side” of addiction
Qian Peng, Chris Bizon, Ian R. Gizer, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 26

Apremilast-induced increases in acute ethanol intoxication and decreases in ethanol drinking in mice involve PKA phosphorylation of GABAA β3 subunits
Yuri A. Blednov, Adriana Da Costa, Sonia Mason, et al.
Neuropharmacology (2022) Vol. 220, pp. 109255-109255
Open Access | Times Cited: 14

Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood
Fulton T. Crews, Leon G. Coleman, Victoria A. Macht, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 2, pp. 380-396
Open Access | Times Cited: 14

Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder
Rui-Ting Wen, Fang-Fang Zhang, Han‐Ting Zhang
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1793-1805
Open Access | Times Cited: 24

Essential role of the mitochondrial Na+/Ca2+ exchanger NCLX in mediating PDE2-dependent neuronal survival and learning
Maya Rozenfeld, Ivana Savic Azoulay, Tsipi Ben Kasus Nissim, et al.
Cell Reports (2022) Vol. 41, Iss. 10, pp. 111772-111772
Open Access | Times Cited: 13

The Functions of Mitochondrial 2′,3′-Cyclic Nucleotide-3′-Phosphodiesterase and Prospects for Its Future
Olga Krestinina, Baburina Yulia, Vassilios Papadopoulos
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3217-3217
Open Access | Times Cited: 18

Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains
C. Leonardo Jimenez Chavez, Camron D. Bryant, Melissa A. Munn‐Chernoff, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5443-5443
Open Access | Times Cited: 16

Alcohol-specific transcriptional dynamics of memory reconsolidation and relapse
Koral Goltseker, Patricia M. Garay, Katherine M. Bonefas, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6

Advancing Pharmacotherapy Development from Preclinical Animal Studies
Mark Egli
Handbook of experimental pharmacology (2018), pp. 537-578
Closed Access | Times Cited: 16

Behavioral Neuroadaptation to Alcohol: From Glucocorticoids to Histone Acetylation
Nicole Mons, Daniel Béracochéa
Frontiers in Psychiatry (2016) Vol. 7
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top